PMID- 16463434 OWN - NLM STAT- MEDLINE DCOM- 20060711 LR - 20220311 IS - 0315-162X (Print) IS - 0315-162X (Linking) VI - 33 IP - 3 DP - 2006 Mar TI - Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. PG - 539-45 AB - OBJECTIVE: . To examine the hypothesis that patients with systemic lupus erythematosus (SLE) have increased concentrations of interleukin-6 (IL-6), IL-8, and monocyte chemoattractant protein-1 (MCP-1) and that these cytokines are associated with coronary risk factors and atherosclerosis. METHODS: Plasma IL-6, MCP-1, and serum IL-8 (pg/ml) concentrations were measured in 74 patients with SLE and in 85 controls. Clinical characteristics, homocysteine, lipids, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and coronary artery calcification as detected by electron beam computed tomography were measured. RESULTS: IL-6 (13.2 +/- 13.8 pg/ml vs 6.7 +/- 3.2 pg/ml, p < 0.001) and MCP-1 (264.2 +/- 581.8 pg/ml vs 131.0 +/- 63.7 pg/ml, p < 0.001) concentrations were higher in patients with lupus than in controls. IL-8 concentrations did not differ between patients and controls (p = 0.86). In patients, IL-6 concentrations were correlated with CRP (p < 0.001), ESR (p < 0.001), SLE disease activity index (SLEDAI, p = 0.003), and body mass index (BMI, p = 0.003). IL-6 concentrations were inversely correlated with HDL cholesterol (p = 0.01). MCP-1 concentrations were correlated with SLEDAI (p = 0.01), ESR (p = 0.04), and triglycerides (p = 0.03). After controlling for age, sex, disease activity, SLICC damage index, smoking status, and systolic blood pressure, IL-6 was associated with coronary calcification (odds ratio, OR = 1.07, p = 0.035). Similar models found no association between MCP-1 or IL-8 with coronary artery calcification. CONCLUSION: Patients with SLE have increased concentrations of IL-6 and MCP-1. These cytokines are associated with increased inflammation, BMI, and adverse lipid profiles. IL-6 is associated with burden of atherosclerosis in SLE. FAU - Asanuma, Yu AU - Asanuma Y AD - Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA. FAU - Chung, Cecilia P AU - Chung CP FAU - Oeser, Annette AU - Oeser A FAU - Shintani, Ayumi AU - Shintani A FAU - Stanley, Eran AU - Stanley E FAU - Raggi, Paolo AU - Raggi P FAU - Stein, C Michael AU - Stein CM LA - eng GR - GM5M01-RR00095/GM/NIGMS NIH HHS/United States GR - HL04012/HL/NHLBI NIH HHS/United States GR - HL65082/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060201 PL - Canada TA - J Rheumatol JT - The Journal of rheumatology JID - 7501984 RN - 0 (Cytokines) SB - IM CIN - J Rheumatol. 2006 Mar;33(3):445-7. PMID: 16511912 CIN - J Rheumatol. 2006 Dec;33(12):2548; author reply 2548-9. PMID: 17143992 MH - Adult MH - Atherosclerosis/blood/*epidemiology/pathology MH - Body Mass Index MH - Comorbidity MH - Cytokines/*blood MH - Female MH - Health Status MH - Humans MH - Lupus Erythematosus, Systemic/blood/*epidemiology/pathology MH - Male MH - Odds Ratio MH - Risk Factors MH - Severity of Illness Index EDAT- 2006/02/08 09:00 MHDA- 2006/07/13 09:00 CRDT- 2006/02/08 09:00 PHST- 2006/02/08 09:00 [pubmed] PHST- 2006/07/13 09:00 [medline] PHST- 2006/02/08 09:00 [entrez] AID - 06/13/024 [pii] PST - ppublish SO - J Rheumatol. 2006 Mar;33(3):539-45. Epub 2006 Feb 1.